Organic chemistry http://www.globalpost.com/taxonomy/term/27372/all en UK's NICE backs wider use of BMS, Pfizer anti-clot drug http://www.globalpost.com/dispatch/news/thomson-reuters/130122/uks-nice-backs-wider-use-bms-pfizer-anti-clot-drug <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>LONDON, Jan 23 (Reuters) - Britain's national health costs watchdog has recommended Bristol-Myers Squibb and Pfizer's anti-clotting pill Eliquis for preventing strokes in patients with an irregular heartbeat condition called atrial fibrillation (AF)</p> <p>The draft guidance from the National Institute for Health and Clinical Excellence (NICE) opens up a potential new market for Eliquis, which belongs to a new class of medicines designed to replace the decades-old blood thinner warfarin.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130122/uks-nice-backs-wider-use-bms-pfizer-anti-clot-drug" target="_blank">read more</a></p> Anticoagulants Business Chemistry Education Health Labor Organic chemistry Politics Technology Thomson Reuters Wed, 23 Jan 2013 00:30:15 +0000 5738089 at http://www.globalpost.com INTERVIEW-Merck CEO says jury out on raising good cholesterol http://www.globalpost.com/dispatch/news/thomson-reuters/130124/interview-merck-ceo-says-jury-out-raising-good-cholesterol <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Role of HDL in heart disease yet to be settled</p> <p>* Anacetrapib study "certainly not a slam dunk"</p> <p>By Ben Hirschler</p> <p>DAVOS, Switzerland, Jan 24 (Reuters) - The jury is still out on the benefits of increasing "good" HDL cholesterol, but the strategy remains worth pursuing, despite recent setbacks, the chief executive of Merck &amp; Co said on Thursday.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130124/interview-merck-ceo-says-jury-out-raising-good-cholesterol" target="_blank">read more</a></p> Chemistry Health Merck & Co Organic chemistry Organofluorides Technology Thomson Reuters Thu, 24 Jan 2013 10:00:04 +0000 5738709 at http://www.globalpost.com AstraZeneca shares slump on tumbling profits, weak outlook http://www.globalpost.com/dispatch/news/afp/130131/astrazeneca-shares-slump-tumbling-profits-weak-outlook <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Shares in AstraZeneca slumped nearly 5.0 percent on Thursday after the Anglo-Swedish drugsmaker said its annual net profits had tumbled on patent expiries and warned that sales would dive further this year.</p> <p>Earnings after tax tanked 37 percent to $6.297 billion (4.645 billion euros) in 2012, compared with $9.983 billion in the previous year, the pharmaceuticals giant announced in a results statement.</p> <p>The blue-chip company added that turnover tumbled 15 percent to $27.973 billion in 2012.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130131/astrazeneca-shares-slump-tumbling-profits-weak-outlook" target="_blank">read more</a></p> AstraZeneca Business Chemistry Health Labor Organic chemistry Social Issues Technology AFP Thu, 31 Jan 2013 15:30:37 +0000 5741779 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130205/reuters-health-news-summary-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>U.S. proposes scrapping some obsolete Medicare regulations 2013-02-05T010951Z_2_BRE914024_RTROPTC_0_US-USA-HEALTHCARE-HOSP ITALS.XML () -</p> <p>Merck hit with $285,000 verdict in Fosamax trial</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130205/reuters-health-news-summary-1" target="_blank">read more</a></p> Chemistry Health Labor Organic chemistry Social Issues Technology War Thomson Reuters Tue, 05 Feb 2013 21:15:45 +0000 5746883 at http://www.globalpost.com CORRECTED-UPDATE 3-FDA approves Roche drug for late-stage breast cancer http://www.globalpost.com/dispatch/news/thomson-reuters/130222/update-3-fda-approves-roche-drug-late-stage-breast-cancer <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Corrects paragraph 5 to show control arm included Xeloda, not Herceptin)</p> <p>* Drug is first of its kind for solid tumors</p> <p>* To carry warnings on liver, heart damage</p> <p>* ImmunoGen shares up 1.9 pct; Roche up 1.5 pct</p> <p>By Toni Clarke</p> <p>WASHINGTON, Feb 22 (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130222/update-3-fda-approves-roche-drug-late-stage-breast-cancer" target="_blank">read more</a></p> Chemistry Disaster Medicine Organic chemistry Religion Technology Thomson Reuters Fri, 22 Feb 2013 21:30:15 +0000 5763798 at http://www.globalpost.com Football: Peruvian club eyes Viagra for on-field boost http://www.globalpost.com/dispatch/news/afp/130227/football-peruvian-club-eyes-viagra-field-boost <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Leading Peruvian football club Alianza Lima is considering the possibility of giving its players Viagra during matches played at altitude in the local championships.</p> <p>In a country where some Peruvian league matches take place in towns between 2,700 and 3,300 metres, Alianza players could be looking at reaping the benefits from the erectile dysfunction drug.</p> <p>"When we were in Spain during pre-season, we talked with the club doctor and he explained to us that Viagra could help improve the physical conditioning of players at altitude," coach Wilmar Valencia said.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130227/football-peruvian-club-eyes-viagra-field-boost" target="_blank">read more</a></p> Football in Peru Human sexuality Organic chemistry AFP Wed, 27 Feb 2013 21:31:31 +0000 5768956 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130301/reuters-health-news-summary-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>FDA staff say calcitonin salmon cancer risk appears plausible 2013-03-01T162332Z_2_BRE9200MB_RTROPTC_0_US-FDA-CALCITONIN.XML () -</p> <p>Melatonin no help for late-stage cancer weight loss</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130301/reuters-health-news-summary-1" target="_blank">read more</a></p> Chemistry Disaster Environment Health Labor Medicine Organic chemistry Social Issues Technology Weather Thomson Reuters Fri, 01 Mar 2013 21:16:12 +0000 5771346 at http://www.globalpost.com Bayer vows to fight for patent on anti-cancer drug in India http://www.globalpost.com/dispatch/news/afp/130304/bayer-vows-fight-patent-anti-cancer-drug-india <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.</p> <p>India's Intellectual Property Appellate Board has rejected an appeal by Bayer against the decision by a local patent authority to grant a license to generics manufacturer Natco Pharma, allowing it to copy Nexavar.</p> <p>The patent authority allowed Natco to make copies of Nexavar on the grounds that Bayer's drug is too expensive for most people in India.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130304/bayer-vows-fight-patent-anti-cancer-drug-india" target="_blank">read more</a></p> Bayer Business Chemistry Health Labor Monopoly Organic chemistry Social Issues Technology AFP Mon, 04 Mar 2013 16:30:47 +0000 5772875 at http://www.globalpost.com UPDATE 3-FDA advisors vote against two drugs for menopausal hot flashes http://www.globalpost.com/dispatch/news/thomson-reuters/130304/update-1-fda-advisers-vote-reject-approval-depomeds-menopause-d <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* U.S. FDA advisory panel votes to reject Depomed's Sefelsa * Panel also rejects Noven Pharmaceuticals menopause drug * Advisors say neither drug confers enough benefit * Depomed shares fall 9.8 percent (Adds panel's rejection of Noven drug) By Toni Clarke WASHINGTON, March 4 (Reuters) - Advisers to the U.S. Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause, concluding that neither conferred enough benefit to offset their risk.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130304/update-1-fda-advisers-vote-reject-approval-depomeds-menopause-d" target="_blank">read more</a></p> Business Chemistry Depomed Inc Medicine Organic chemistry Pharmaceutical sciences Pharmacology Social Issues Thomson Reuters Mon, 04 Mar 2013 18:15:11 +0000 5773080 at http://www.globalpost.com Sleep aids tied to hip fractures in the elderly http://www.globalpost.com/dispatch/news/thomson-reuters/130306/sleep-aids-tied-hip-fractures-the-elderly <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>March 7 (Reuters) - Nursing home residents taking sleep aids such as Ambien are more likely to fall and fracture a hip than residents not being treated for insomnia, according to a U.S. study.</p> <p>Hip fractures account for more than 320,000 hospital admissions every year in the United States and are a major source of disability among seniors.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130306/sleep-aids-tied-hip-fractures-the-elderly" target="_blank">read more</a></p> Chemistry Nonbenzodiazepines Organic chemistry Social Issues Thomson Reuters Thu, 07 Mar 2013 02:00:18 +0000 5775629 at http://www.globalpost.com Viagra is no help against heart failure: study http://www.globalpost.com/dispatch/news/afp/130311/viagra-no-help-against-heart-failure-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>The erectile dysfunction drug commonly known as Viagra is no help against heart failure and should not be taken for it, according to research out Monday that contradicts previous, smaller studies.</p> <p>Some early research had suggested the drug, which can increase blood flow to other parts of the body, might offer a benefit to people with diastolic heart failure in which the heart's lower chambers stiffen and cannot pump blood well, causing shortness of breath.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130311/viagra-no-help-against-heart-failure-study" target="_blank">read more</a></p> Chemistry Health Medicine Organic chemistry AFP Mon, 11 Mar 2013 21:00:39 +0000 5780112 at http://www.globalpost.com Arrhythmia drug may increase cancer risk http://www.globalpost.com/dispatch/news/afp/130409/arrhythmia-drug-may-increase-cancer-risk <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A common treatment for irregular heartbeats may have a serious side effect: a new study out Tuesday showed it could increase the risk for certain cancers, especially among men.</p> <p>The research, published in the US journal CANCER, found that individuals taking a high dose of amiodarone for a long time had twice the risk of developing cancer as those taking a low amount of the drug.</p> <p>And the numbers were especially high among men who had taken the drug daily at high doses for the first year.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130409/arrhythmia-drug-may-increase-cancer-risk" target="_blank">read more</a></p> Antiarrhythmic agents Chemistry Health Labor Organic chemistry Social Issues AFP Wed, 10 Apr 2013 01:30:29 +0000 5808589 at http://www.globalpost.com CORRECTED: Arrhythmia drug may increase cancer risk http://www.globalpost.com/dispatch/news/afp/130410/corrected-arrhythmia-drug-may-increase-cancer-risk <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A common treatment for irregular heartbeats may have a serious side effect: a new study out Tuesday showed it could increase the risk for certain cancers, especially among men.</p> <p>The research, published in the US journal CANCER, found that individuals taking a high dose of amiodarone for a long time had twice the risk of developing cancer as those taking a low amount of the drug.</p> <p>And the numbers were especially high among men who had taken the drug daily at high doses for the first year.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130410/corrected-arrhythmia-drug-may-increase-cancer-risk" target="_blank">read more</a></p> Antiarrhythmic agents Chemistry Organic chemistry AFP Wed, 10 Apr 2013 16:15:58 +0000 5808978 at http://www.globalpost.com Boston bombs were likely homemade, full of shrapnel http://www.globalpost.com/dispatch/news/afp/130416/boston-bombs-were-likely-homemade-full-shrapnel <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>The explosives used in the Boston Marathon bombings were likely homemade devices full of nails and metal fragments designed to cause widespread injury, according to initial reports.</p> <p>A day after an attack that left three dead and more than 170 wounded, the FBI and Boston police declined to reveal details of their probe, or whether they suspected the assault was linked to foreign or domestic extremists.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130416/boston-bombs-were-likely-homemade-full-shrapnel" target="_blank">read more</a></p> Chemistry Improvised explosive devices Organic chemistry War AFP Tue, 16 Apr 2013 19:13:28 +0000 5817687 at http://www.globalpost.com OFT accuses GSK over "pay-for-delay" drug deals http://www.globalpost.com/dispatch/news/thomson-reuters/130419/oft-accuses-gsk-over-pay-delay-drug-deals <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Ben Hirschler</p> <p>LONDON (Reuters) - The Office of Fair Trading (OFT) accused GlaxoSmithKline &lt;GSK.L&gt; of market abuse for striking deals with three generic drugmakers that paid them to delay launching cheap copies of its antidepressant Seroxat.</p> <p>GSK, Britain's biggest drugmaker, said it believed it had acted lawfully. If it is found to have broken the law, it could be fined up to 10 percent of its worldwide turnover, which amounted to 26.4 billion pounds in 2012.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130419/oft-accuses-gsk-over-pay-delay-drug-deals" target="_blank">read more</a></p> Business Chemistry GlaxoSmithKline Health Hospitality Labor Law Organic chemistry Pharmaceutical sciences Politics Social Issues Thomson Reuters Fri, 19 Apr 2013 07:00:04 +0000 5819959 at http://www.globalpost.com